Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.077 AUD Market Closed
Market Cap: 92.5m AUD

Intrinsic Value

ALA doesn't have a meaningful market cap.

The intrinsic value of one ALA stock under the Base Case scenario is 0.01 AUD. Compared to the current market price of 0.077 AUD, Arovella Therapeutics Ltd is Overvalued by 87%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALA Intrinsic Value
0.01 AUD
Overvaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Arovella Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ALA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ALA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Arovella Therapeutics Ltd.

Explain Valuation
Compare ALA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arovella Therapeutics Ltd

Current Assets 21.2m
Cash & Short-Term Investments 20.9m
Other Current Assets 292.5k
Non-Current Assets 430.6k
PP&E 430.6k
Current Liabilities 1.5m
Accounts Payable 1.4m
Other Current Liabilities 131.6k
Non-Current Liabilities 31.6k
Other Non-Current Liabilities 31.6k
Efficiency

Free Cash Flow Analysis
Arovella Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arovella Therapeutics Ltd

Revenue
525.5k AUD
Operating Expenses
-8m AUD
Operating Income
-7.5m AUD
Other Expenses
800 AUD
Net Income
-7.5m AUD
Fundamental Scores

ALA Profitability Score
Profitability Due Diligence

Arovella Therapeutics Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

51/100
Profitability
Score

Arovella Therapeutics Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

ALA Solvency Score
Solvency Due Diligence

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALA Price Targets Summary
Arovella Therapeutics Ltd

There are no price targets for ALA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Arovella Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ALA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ALA stock?

The intrinsic value of one ALA stock under the Base Case scenario is 0.01 AUD.

Is ALA stock undervalued or overvalued?

Compared to the current market price of 0.077 AUD, Arovella Therapeutics Ltd is Overvalued by 87%.

Back to Top